Rivastigmina is a new oral prescription drug approved by the US Food and Drug Administration (FDA). It was developed by AstraZeneca, a pharmaceutical company based in Rockville, Maryland. As with any new prescription medication, it must be thoroughly studied before it is approved for sale, and consumers must understand what Rivastigmina contains before they can buy it.One of the most important...